Acasti Pharma, Inc. (ACST) Financials

ACST Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 57.4 million 8.7 million
2023-09-30 57.5 million 8.4 million
2023-06-30 55.2 million 6.8 million
2023-03-31 58.5 million 8.3 million

ACST Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 -1.4 million 245787
2023-09-30 -1.6 million 206026
2023-06-30 -4.7 million 58921
2023-03-31 -2.5 million 238005

ACST Net Income

No data available :(

ACST Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 18.9 million - 18094
2023-09-30 19.9 million - 33847
2023-06-30 16.4 million - 60431
2023-03-31 20.6 million - 358485

ACST Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 8.7 million
2023-09-30 5.6 million
2023-06-30 5.6 million
2023-03-31 5.5 million

ACST Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 1.1 million 1.2 million 22618
2023-09-30 - 338471 1.2 million 31639
2023-06-30 - 827162 1.4 million 45323
2023-03-31 5913 1.2 million 1.8 million 37696

ACST Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 - 2.3 million
2023-09-30 - 1.5 million
2023-06-30 - 3.4 million
2023-03-31 -23652 10.4 million

ACST

Price: $2.96

52 week price:
1.72
3.84

Payout Ratio Range:
-107.58%
-75.79%

Earnings Per Share: -5.68 USD

P/E Ratio: -0.41

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 172300

Ebitda: -8.8 million

Market Capitalization: 32.0 million

Links: